Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse.
Saved in:
| Title: | Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse. |
|---|---|
| Authors: | Bobillo S; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Medicine, Universitat Autonoma de Barcelona, Barcelona, Spain., Joffe E; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sermer D; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mondello P; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ghione P; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Caron PC; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hamilton A; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hamlin PA; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Horwitz SM; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Kumar A; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Matasar MJ; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Batlevi CL; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Moskowitz A; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Noy A; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Owens CN; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Palomba ML; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Straus D; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Department of Medicine, Weill Cornell Medical College, New York, NY, USA., von Keudell G; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Dogan A; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zelenetz AD; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Seshan VE; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Younes A; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. anas.younes@astrazeneca.com.; Weill Cornell Department of Medicine, Weill Cornell Medical College, New York, NY, USA. anas.younes@astrazeneca.com. |
| Source: | Blood cancer journal [Blood Cancer J] 2021 Jun 16; Vol. 11 (6), pp. 113. Date of Electronic Publication: 2021 Jun 16. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
